Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+

Source link :

A certain type of bariatric surgery may prove more cost-effective over time than a popular weight loss drug, an economic evaluation study suggested. In an analysis of adults with class II obesity (BMI 35-39.9), endoscopic sleeve gastroplasty (ESG) added 0.06 more quality-adjusted life-years while costing $33,583 less than semaglutide (Wegovy) over 5 years, Christopher Thompson, […]

Author : News Health

Publish date : 2024-04-12 17:03:14

Copyright for syndicated content belongs to the linked Source.